Bioventus Inc. (NASDAQ: BVS)

Bioventus Inc., a global medical device company with the ticker symbol BVS, is dedicated to developing and commercializing clinically differentiated, cost-efficient, and minimally invasive treatments that engage and enhance the body's natural healing process. The company operates in the medical device industry and manages its business through two reporting segments: U.S. and International, which accounted for 88% and 12%, respectively, of its total net sales during the fiscal year ended December 31, 2023.

Bioventus's main business activities revolve around the development and commercialization of medical devices that cater to the orthopedic, neurosurgical, and reconstructive markets. The company operates in various countries, including the United States, Canada, Europe, and Japan. Its portfolio of products is grouped into three areas: Pain Treatments, Surgical Solutions, and Restorative Therapies.

The company generates revenue through its primary products and services in the Pain Treatments segment, which includes hyaluronic acid-based products for knee osteoarthritis and peripheral nerve stimulation devices. Specifically, the Pain Treatments segment includes a range of products, such as Durolane, GELSYN-3, SUPARTZ FX, and StimRouter. Durolane is a single injection therapy that is indicated for the symptomatic treatment of osteoarthritis in the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy and simple analgesics. GELSYN-3 and SUPARTZ FX are three- and five-injection therapies, respectively, that are used to treat pain due to knee osteoarthritis. StimRouter is a permanent option that provides relief for chronic peripheral pain, including nerve pain, neuroma, neuropathic pain, post-stroke shoulder pain, and neuralgia.

In the Surgical Solutions segment, Bioventus offers a range of products, including OSTEOAMP, EXPONENT, PUREBONE, SIGNAFUSE, INTERFACE, OSTEOMATRIX+, EXTRACTOR, Reficio Demineralized Bone Matrix, and the neXus Ultrasonic Surgical System. OSTEOAMP is an allograft-derived bone graft with growth factors used for orthopedic, neurosurgical, and reconstructive bone grafting procedures. EXPONENT is an osteoconductive scaffold with osteoinductive potential used for posterolateral spine procedures. PUREBONE is a natural osteoconductive scaffold that facilitates cellular ingrowth and revascularization used for orthopedic, neurosurgical, and reconstructive bone grafting procedures. SIGNAFUSE is a synthetic bone graft with exceptional handling, rapid hydration, and a biphasic composition used for posterolateral spine, extremities, and pelvis procedures. INTERFACE is a synthetic bone graft with a synergistic combination of biomaterials that supports new bone formation used for posterolateral spine, extremities, and pelvis procedures. OSTEOMATRIX+ is a synthetic bone graft with exceptional handling, rapid hydration, and a biphasic composition used for posterolateral spine, extremities, and pelvis procedures. EXTRACTOR is a cannula designed for marrow extraction used for orthopedic, neurosurgical, and reconstructive procedures. Reficio Demineralized Bone Matrix is a putty comprised of human demineralized bone matrix and a biocompatible bioabsorbable carrier used for bone void filler and bone graft substitute procedures. The neXus Ultrasonic Surgical System is a next-generation integrated ultrasonic surgical platform that combines all the features of the company's existing Surgical Solutions applications.

Bioventus has a strong position within the industry, with a diverse portfolio of products that cater to a range of markets, including orthopedic, neurosurgical, and reconstructive procedures. Key competitors in the industry include other medical device companies that develop and commercialize products for orthopedic, neurosurgical, and reconstructive procedures. Bioventus's competitive advantages include its range of options for treating patients with various conditions and its focus on engaging and enhancing the body's natural healing process.

The company's customers include hospitals, ambulatory surgical centers, and physician practices, and its products are used by clinicians around the world. Specific names of customers are not provided in the text.